Ep. 7 of the Optimizing Fertility podcast
Ovulation tests aims to tell us when we are most likely to conceive and to help us get pregnant faster. But with many different options on the market, and some criticism from OGYNS and fertility doctors around at-home testing, how can we navigate what works and what doesn’t?
In this episode we hear from OOVA founder and biologist Dr. Amy Divaraniya, whose startup has reinvented ovulation monitoring with the launch of its non-invasive, lab-quality "fertility translator" kit.
Amy talks to ELANZA Wellness’s Catherine Hendy about how her own struggle to get pregnant left her frustrated with the one size fits all approach of traditional tracking, what we can learn by monitoring our hormone changes and patterns, and how she set about reinventing a test without the drawbacks of existing ovulation tests.
You can also watch a video version of this interview or read the full transcript posted in the ELANZA Community by clicking here.
Dr. Aparna (Amy) Divaraniya has a PhD in genetics and genomics from the Icahn School of Medicine at Mount Sinai. She is the Co-Founder and CEO of OOVA, a hormone measurement tool used to help women understand their fertility on a deeper and more comprehensive level.